Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with Target = 'Genome polyprotein [1973-2419]'
TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241850(US9416139, 28)
Affinity DataEC50:  0.763nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241842(US9416139, 20)
Affinity DataEC50:  0.685nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241843(US9416139, 21)
Affinity DataEC50:  0.0290nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241844(US9416139, 22)
Affinity DataEC50:  0.0720nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241845(US9416139, 23)
Affinity DataEC50:  0.0470nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241846(US9416139, 24)
Affinity DataEC50:  0.0990nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241847(US9416139, 25)
Affinity DataEC50:  0.103nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241848(US9416139, 26)
Affinity DataEC50:  0.216nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241849(US9416139, 27)
Affinity DataEC50:  0.323nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241823(US9416139, 2 | US9416139, 1)
Affinity DataEC50:  0.0870nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241851(US9416139, 29)
Affinity DataEC50:  0.00900nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241852(US9416139, 30)
Affinity DataEC50:  0.0520nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241853(US9416139, 31)
Affinity DataEC50:  0.539nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241854(US9416139, 32)
Affinity DataEC50:  0.446nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241855(US9416139, 33)
Affinity DataEC50:  0.0220nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241856(US9416139, 34)
Affinity DataEC50:  0.0550nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241857(US9416139, 35)
Affinity DataEC50:  0.103nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241858(US9416139, 36)
Affinity DataEC50:  0.0620nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241840(US9416139, 18)
Affinity DataEC50:  0.0650nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241841(US9416139, 19)
Affinity DataEC50:  0.436nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241823(US9416139, 2 | US9416139, 1)
Affinity DataEC50:  0.0420nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241825(US9416139, 3)
Affinity DataEC50:  0.0400nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241826(US9416139, 4)
Affinity DataEC50:  0.0160nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241827(US9416139, 5)
Affinity DataEC50:  0.0230nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241828(US9416139, 6)
Affinity DataEC50:  0.0770nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241829(US9416139, 7)
Affinity DataEC50:  0.103nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241830(US9416139, 8)
Affinity DataEC50:  0.0650nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241831(US9416139, 9)
Affinity DataEC50:  0.0720nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241832(US9416139, 11 | US9416139, 10)
Affinity DataEC50:  0.438nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241832(US9416139, 11 | US9416139, 10)
Affinity DataEC50:  0.0320nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241834(US9416139, 12)
Affinity DataEC50:  0.0490nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241835(US9416139, 13)
Affinity DataEC50:  0.273nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241836(US9416139, 14)
Affinity DataEC50:  0.0130nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241837(US9416139, 15)
Affinity DataEC50:  0.142nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241838(US9416139, 16)
Affinity DataEC50:  0.0360nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM241839(US9416139, 17)
Affinity DataEC50:  0.00600nMAssay Description:The Huh-7 cells transfected with HCV replicons system were seeded into 96-well plates (8,000 cells in 125 μL/well) respectively; each test compoun...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244109(US9428491, 1.2: 2HCl)
Affinity DataIC50: 0.000790nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244111(US9428491, 1.4: 2HCl)
Affinity DataIC50: 0.00180nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244105(US9428491, 1.10: 2HCl)
Affinity DataIC50: 0.00200nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244106(US9428491, 1.1: 2HCl | US9428491, 1.1: naphtalene-...)
Affinity DataIC50: 0.00310nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244114(US9428491, 1.9: 2HCl)
Affinity DataIC50: 0.00320nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244106(US9428491, 1.1: 2HCl | US9428491, 1.1: naphtalene-...)
Affinity DataIC50: 0.00340nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244104(US9428491, 1.7: 2HCl)
Affinity DataIC50: 0.00360nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244106(US9428491, 1.1: 2HCl | US9428491, 1.1: naphtalene-...)
Affinity DataIC50: 0.00400nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244108(US9428491, 1.6: 2HCl)
Affinity DataIC50: 0.00460nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244113(US9428491, 1.8: 2HCl)
Affinity DataIC50: 0.00480nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244110(US9428491, 1.3: 2HCl)
Affinity DataIC50: 0.00540nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM244112(US9428491, 1.5: 2HCl)
Affinity DataIC50: 0.00820nMT: 2°CAssay Description:Solutions of the tested compounds in DMEM medium {DMEM) 1x; Source: Cellgro; Catalogue: 10-013-CV} were prepared immediately before use. Eleven seria...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/21/2017
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM466325(US10793591, Compound 76)
Affinity DataIC50: 1.00E+3nMAssay Description:The enzyme activity of NS5B570-Con1 (Delta-21) was measured as an incorporation of tritiated NMP into acid-insoluble RNA products. The complementary ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
Go to US Patent

TargetGenome polyprotein [1973-2419](HCV)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM466324(US10793591, Compound 69)
Affinity DataIC50: 1.00E+3nMAssay Description:The enzyme activity of NS5B570-Con1 (Delta-21) was measured as an incorporation of tritiated NMP into acid-insoluble RNA products. The complementary ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: